Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03904264 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptability of Using Low-Gain Hearing Aids for Bothersome Tinnitus
A NA study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
NCT03904264: Completed NA study, sponsored by VA Office of Research and Development.
NCT03904264 is a NA study that has completed, run by VA Office of Research and Development. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03904264, a NA study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
Study Summary
Tinnitus - defined as ringing, humming, or other sounds in the ears or head - is a very common problem for Veterans. Hearing aids that deliver low-level amplification are being used by audiologists to help people with tinnitus who also have normal hearing. However, there is a lack of research evidence showing that this practice is effective. Despite this fact, the practice clearly is spreading. Reports from audiologists in the field as well as research presentations refer to hearing aids being used in this way. Use of hearing aids has been shown to reduce distress from tinnitus for people with hearing loss. Additionally, the use of external sound to help reduce the impact of tinnitus has been shown to be effective. There is clearly a gap in the research regarding the use of hearing aids as a therapeutic method to manage tinnitus when hearing is considered normal. This study will obtain pilot data evaluating people with normal hearing and bothersome tinnitus to find out whether low-level amplification through hearing aids may provide benefit.
Interventions
- DEVICE Receiver in the canal (RIC) hearing aids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2022-09-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03904264
The ClinicalTrials.gov registry entry for NCT03904264 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Receiver in the canal (RIC) hearing aids is the first listed.
NCT03904264 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03904264 about?
NCT03904264 is a clinical study titled "Feasibility and Acceptability of Using Low-Gain Hearing Aids for Bothersome Tinnitus". Tinnitus - defined as ringing, humming, or other sounds in the ears or head - is a very common problem for Veterans. Hearing aids that deliver low-level amplification are being used by audiologists to help people with tinnitus who also have normal hearing. However, there is a lack of research eviden...
What is the current status of trial NCT03904264?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2020-02-24. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT03904264?
The interventions under investigation include: Receiver in the canal (RIC) hearing aids (DEVICE).
Who is sponsoring clinical trial NCT03904264?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.